Aaron Kantoff | BiotechTV

top of page

BioVenture VoiCes Episode 21: Scion Life Sciences' Aaron Kantoff

Aaron Kantoff describes the road on the public markets side that eventually led him to venture, and recalls successful investments he...

BioVenture VoiCes

Jun 16

The co-founder of Scion Life Sciences on coming out of stealth mode and the new $310 million venture fund announced this week

Aaron Kantoff describes Scion's mission and investment strategy and shares his thoughts on the current state of biotech.

Bright Minds

Feb 9, 2024

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.

Learn more about Genezen

bottom of page

BioVenture VoiCes Episode 21: Scion Life Sciences' Aaron Kantoff

The co-founder of Scion Life Sciences on coming out of stealth mode and the new $310 million venture fund announced this week

Follow BiotechTV

Sponsors

Sponsor Spotlight